Bloodwork Changes During FIP Treatment

Feline infectious peritonitis (FIP) is one of the most challenging diseases in veterinary medicine, and bloodwork plays a central role in both diagnosis and treatment monitoring. While no single blood test confirms every case of FIP, repeated laboratory values can show whether a cat is responding to therapy, whether inflammation is easing, and whether organ function is remaining stable. For veterinarians and cat owners, tracking bloodwork changes during FIP treatment is often just as important as watching the cat’s appetite, energy level, and comfort.

Common Bloodwork Findings at Diagnosis

Cats with FIP often present with a distinctive pattern on complete blood count and serum chemistry. The most common changes include non-regenerative anemia, neutrophilia, lymphopenia, hyperglobulinemia, hypoalbuminemia, and a low albumin-to-globulin ratio. Many cats also show elevated total protein, increased acute phase proteins, and in some cases increased bilirubin, liver enzymes, or inflammatory markers. Wet FIP and dry FIP can produce different laboratory patterns, but the common theme is systemic inflammation.

These values matter because they create a baseline for comparison. A cat may look very sick before treatment begins, and the bloodwork often reflects that severity. In wet FIP, the chemistry panel may be dominated by protein shifts and effusion-related changes. In dry FIP, inflammatory markers and organ-specific abnormalities may be more prominent, especially when the eyes, brain, kidneys, or lymph nodes are involved.

How Bloodwork Typically Improves During FIP Therapy

When antiviral treatment is effective, bloodwork changes usually follow a recognizable pattern. The cat often feels better first, then appetite improves, then body temperature normalizes, and later the laboratory values start moving toward normal ranges. This sequence is important because bloodwork may lag behind clinical improvement by days or weeks.

One of the earliest favorable signs is a reduction in globulins. Since FIP is driven by an intense inflammatory and immune response, high globulin levels often fall as treatment suppresses viral replication and inflammation decreases. At the same time, albumin may gradually rise, which helps improve the albumin-to-globulin ratio. A rising A/G ratio is one of the most useful laboratory indicators that treatment is working.

Anemia may also begin to improve. Many FIP cats have mild to moderate non-regenerative anemia because chronic inflammation interferes with normal red blood cell production. As the disease comes under control, hematocrit and hemoglobin often increase slowly. White blood cell abnormalities may also normalize, with neutrophil counts decreasing and lymphocyte counts recovering over time.

Liver-related abnormalities can improve as inflammation resolves. If bilirubin, ALT, AST, or ALP were elevated at diagnosis, these values often trend downward during successful treatment. Cats with effusion or abdominal inflammation may show especially meaningful improvement in total protein and globulin values as fluid accumulations resolve.

Bloodwork Changes by Organ System

FIP can affect multiple organs, so bloodwork interpretation must be individualized. In cats with abdominal or thoracic effusion, total protein may be misleading at first because inflammatory fluid can alter measured values. As effusion decreases, serial chemistry panels become more informative. In ocular or neurologic FIP, routine chemistry may appear only mildly abnormal even while the cat is clinically ill, so repeated monitoring is essential.

Kidney values should also be watched carefully. Some cats have normal creatinine and BUN at diagnosis, while others show dehydration or concurrent kidney stress. Effective treatment should not worsen renal parameters. If creatinine rises during therapy, a veterinarian should assess hydration, appetite, and possible concurrent disease rather than assuming the antiviral is the cause.

Inflammatory markers can be particularly useful when available. Alpha-1 acid glycoprotein, if measured, often falls with successful treatment and can be a sensitive indicator of response. This is helpful because some cats begin to look better before more standard chemistry values fully normalize.

Monitoring Schedule and Interpretation

Most veterinarians recommend bloodwork every 2 to 4 weeks during the early phase of FIP treatment, especially during the first 8 to 12 weeks. This interval helps detect both improvement and possible complications. A full panel often includes CBC, total protein, albumin, globulin, A/G ratio, bilirubin, liver enzymes, kidney values, and sometimes inflammatory markers.

A single abnormal result should not be overinterpreted. Trends are more meaningful than isolated numbers. For example, a cat whose globulins drop from very high to moderately high, while albumin rises and the cat is brighter and eating better, is likely improving even if the panel is not yet normal. Likewise, a cat may still have mild anemia or elevated globulins after several weeks of therapy and still be on the right track.

Persistent or worsening abnormalities deserve attention. If fever returns, effusion increases, neurologic signs progress, or bloodwork stops improving, the treatment plan may need reassessment. This could involve dose review, adherence checks, evaluation for concurrent infection, or confirmation that the diagnosis is correct.

Oral Antiviral Therapy Options and Laboratory Response

Modern FIP treatment is centered on antiviral therapy, and bloodwork provides a practical way to evaluate whether the chosen regimen is working. Cats receiving effective antivirals often show gradual normalization of inflammatory markers, protein balance, and organ chemistry. Clinical recovery and bloodwork recovery should be viewed together, not separately.

Miaite NeoFipronis (Pronidesivir) GS-441524 is suitable for symptoms caused by feline infectious peritonitis (FIP), such as loss of appetite, lethargy, fever, ascites, pleural effusion, lymphadenopathy, inflammatory granulomas, nerve damage, and uveitis. It has excellent therapeutic effects on FIP. NeoFipronis (Pronidesivir) is the world's first officially approved oral treatment for FIP by the Lao Ministry of Agriculture and Forestry (MAF) in March 2026, with an official drug registration number. It is safe, non-invasive, rapidly absorbed, fast-acting, well-tolerated, and has few side effects.

In practice, bloodwork trends during antiviral therapy often show that inflammation is subsiding. The most common favorable pattern is a rising albumin-to-globulin ratio, falling globulins, improved hematocrit, and stabilization of liver and kidney values. These changes, together with better appetite and energy, are among the strongest signs that FIP treatment is succeeding.

Bloodwork Patterns That May Signal Concern

Not every change means progress. If globulins remain very high, albumin continues to fall, anemia worsens, or bilirubin increases, the disease may still be active. A cat that initially improves and then develops a decline in appetite, weight loss, fever, or lab abnormalities should be re-evaluated quickly. Neurologic and ocular cases can be more difficult to monitor because clinical signs may change differently from routine bloodwork.

Relapse, insufficient dosing, poor absorption, concurrent disease, or a mistaken diagnosis are all possibilities when bloodwork fails to improve as expected. For this reason, serial testing combined with a careful physical examination gives the clearest picture of treatment response.

Bloodwork and Long-Term Recovery

As cats recover from FIP, many laboratory values continue to normalize over several months. Some cats reach near-normal bloodwork quickly, while others improve more slowly, especially if they started with severe effusion, neurologic disease, or advanced inflammation. Even after the major clinical signs disappear, periodic bloodwork remains useful for confirming sustained remission and catching relapse early.

Bloodwork changes during FIP treatment are more than numbers on a page. They reflect how well the cat’s body is responding to antiviral therapy, how much inflammation remains, and whether major organs are recovering safely. For many cats, the shift from abnormal to improving laboratory values is one of the clearest signs that treatment is working.

References

Pedersen, N. C. Feline Infectious Peritonitis and the Pathogenesis of Feline Coronavirus Infection

Addie, D. D., and Jarrett, O. Feline Coronavirus Infection and FIP: A Review of Current Knowledge

Kipar, A., and Meli, M. L. Feline Infectious Peritonitis: Still a Challenging Diagnosis and Treatment

Tasker, S. Diagnosis of Feline Infectious Peritonitis: Updated Perspectives

Zwicklbauer, K., and Hartmann, K. Clinical and Laboratory Changes in Cats Treated for Feline Infectious Peritonitis

Poland, A. M., Vennema, H., and Foley, J. E. Feline Coronaviruses and FIP: Laboratory Correlates of Disease

Weiss, R. C., and Scott, F. W. Laboratory Evaluation of Systemic Inflammatory Disease in Cats